• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

News

Article

June 11, 2024

Study Finds Link Between Xylitol and Increased Risk of Heart Attack, Stroke

Author(s):

Alexandra Gerlach, Associate Editor

Research has found that increased consumption of sugar alcohols, like xylitol, may increase risk of cardiovascular events.

Researchers from Cleveland Clinic have linked xylitol, a common sugar substitute, to increased risk of heart attack and stroke. Their study, published in the European Heart Journal, highlights potential health concerns associated with xylitol and other sugar alcohols in adults. The finding underscores the need for further investigation into the safety of artificial sweeteners and their impact on cardiovascular health.

xylitol sugar substitute

Sugar alcohols are polyols and hydrogenated carbohydrates that are often labeled as “natural” because they can be extracted from berries. Image Credit: © mnimage - stock.adobe.com

Artificial sweeteners have been largely accepted by the general population, as well as the scientific community, as a beneficial supplement to reduce excess sugar intake. Xylitol is a sugar alcohol widely used as a sugar substitute in sugar-free candy, gums, baked goods, and toothpaste and is a rapidly growing market reaching $701.3 million in profits in 2023.1

Sugar alcohols are polyols and hydrogenated carbohydrates that are often labeled as “natural” because they can be extracted from berries, oats, corn husk, birch, and sugarcane bagasse. However, xylitol is also produced by the body in very low levels, typically much lower than levels used in food production. Compared with endogenous production of xylitol, ingested xylitol has a shorter plasma half-life, with peak plasma levels occurring after 30 minutes with rapid metabolism of 80% by the liver.1

Xylitol is similar to sucrose but has fewer calories per gram (2.4 kcal/g or 9 kJ/g vs 4 kcal/g or 17 kJ/g for typical sugars). Various countries and medical organizations tout positive side effects of ingesting xylitol, claiming associations with oral health, fewer respiratory infections, and increased satiety. However, findings by Cleveland Clinic researchers show that ingesting xylitol in a 1000-fold plus quantity can enhance platelet reactivity and thrombosis potential in vivo.1-3

The study involved more than 3000 patients from the United States and Europe who were divided into 3 cohorts: (1) a discovery cohort consisting of 1157 participants whose fasting plasma samples underwent elective diagnostic cardiac evaluations for untargeted metabolomics study; (2) an independent validation cohort with 2149 participants whose plasma was used for subsequent stable isotope dilution liquid chromatography tandem mass spectrometry (LC-MS/MS) analyses; and (3) an intervention study cohort involving 10 healthy participants to assess the direct effects of xylitol consumption on platelet function.3

The researchers performed complementary experiments using isolated human platelets, platelet-rich plasma, whole blood, and animal models to examine the effects of xylitol consumption on platelet responsiveness and thrombosis in vivo. The results from subsequent stable isotope dilution liquid chromatography with tandem mass spectrometry analyses identified that high levels of circulating xylitol in the body are associated with incident (3-year) major adverse cardiovascular event (MACE) risk (third vs. first tertile adjusted hazard ratio [95% confidence interval], 1.57 [1.12–2.21], P < .01).1,3

Among the 3000 participants, one-third of patients with the highest plasma levels had an elevated likelihood of experiencing a cardiovascular event. The study authors found that consumption of products containing xylitol compared to glucose significantly raised platelet responsiveness in all participants, which may contribute to thrombosis, heart attack, or stroke.1,2

Further investigation into the effects of xylitol consumption on cardiovascular health is warranted due to several limitations, including the study’s demonstration of association and not causation. As a result, the study authors recommend referring to a health care professional for advice about healthy eating habits.2

“It does not mean throw out your toothpaste if it has xylitol in it,” Stanley Hazen, MD, PhD, chair of cardiovascular and metabolic sciences at Cleveland Clinic’s Lerner Research Institute, said in a press release, “but we should be aware that consumption of a product containing high levels could increase the risk of blood clot related events.”2

References
1. Beer J, Allemann M. Xylitol: bitter cardiovascular data for a successful sweetener. European Heart Journal, June 6, 2024. https://doi.org/10.1093/eurheartj/ehae252
2. Cleveland clinic-led study links sugar substitute to increased risk of heart attack and stroke. EurekAlert. June 6, 2024. June 10, 2024. https://www.eurekalert.org/news-releases/1046958
3. Witkowski M, Nemet I, Li X, et al. Xylitol is prothrombotic and associated with cardiovascular risk. European Heart Journal, June 6, 2024. https://doi.org/10.1093/eurheartj/ehae244

Related Videos
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com
Older patient with medical health checkup with cardiologist or geriatric doctor. Woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Related Content
Advertisement
Illustration of myocardial infarction
May 30th 2025

NLA 2025: Inclisiran With Standard Care Provides Rapid, Sustained Lowering of LDL-C in Patients With Recent Acute Coronary Syndrome

Luke Halpern, Assistant Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Washington, DC, USA - June 24, 2022: The symbol of the U.S. Department of Health and Human Services is seen at the entrance to its headquarters in the Hubert H. Humphrey Building in Washington, DC
May 30th 2025

HHS Cancels Millions in Pandemic Influenza mRNA Vaccine Development Grants

Luke Halpern, Assistant Editor
Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial
May 20th 2025

Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Oral prescription opioids -- Image credit: steheap | stock.adobe.com
May 30th 2025

Streamlining Pain Management: Shore Medical Center's Pharmacist-Driven Opioid Conversion Initiative

Gillian McGovern, Associate Editor Elizabeth DeMarco, PharmD, BCPS
Centennial Pharmacy Services in Pennsylvania Highlights a Lifelong Passion for Patient Care
May 30th 2025

Centennial Pharmacy Services in Pennsylvania Highlights a Lifelong Passion for Patient Care

Karen Berger, PharmD
Related Content
Advertisement
Illustration of myocardial infarction
May 30th 2025

NLA 2025: Inclisiran With Standard Care Provides Rapid, Sustained Lowering of LDL-C in Patients With Recent Acute Coronary Syndrome

Luke Halpern, Assistant Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Washington, DC, USA - June 24, 2022: The symbol of the U.S. Department of Health and Human Services is seen at the entrance to its headquarters in the Hubert H. Humphrey Building in Washington, DC
May 30th 2025

HHS Cancels Millions in Pandemic Influenza mRNA Vaccine Development Grants

Luke Halpern, Assistant Editor
Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial
May 20th 2025

Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Oral prescription opioids -- Image credit: steheap | stock.adobe.com
May 30th 2025

Streamlining Pain Management: Shore Medical Center's Pharmacist-Driven Opioid Conversion Initiative

Gillian McGovern, Associate Editor Elizabeth DeMarco, PharmD, BCPS
Centennial Pharmacy Services in Pennsylvania Highlights a Lifelong Passion for Patient Care
May 30th 2025

Centennial Pharmacy Services in Pennsylvania Highlights a Lifelong Passion for Patient Care

Karen Berger, PharmD
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.